Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04062
Species: Homo sapiens
Position : chr8:128413136-128414674
Year: 2016
Title: 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  26934861
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: LNCaP
CVCL ID: CVCL_0395
Cell Type: epithelial cell
Cell Ontology ID: CL:0000066
Experiment Type: Chromatin interaction assay; Enhancer activity assay; Genetic risk regulatory analysis; Disease-variant functional analysis
High Throughput Method: 4C-seq; Public ChIP-seq and epigenomic data integration; GWAS
Low Throughput Method: Luciferase Reporter Assay; Transgenic Reporter Assay; 4C
About Target Gene
Target gene : MYC
About TF
TF name : TCF7L2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TCF7L2 Alzheimer disease-presenilin pathway panther 98
TCF7L2 Angiogenesis panther 141
TCF7L2 AP-1 transcription factor network pid 71
TCF7L2 Binding of TCF/LEF:CTNNB1 to target gene promoters reactome 7
TCF7L2 Ca2+ pathway reactome 62
TCF7L2 Cadherin signaling pathway panther 147
TCF7L2 Canonical Wnt signaling pathway ( C. elegans endoderm induction Wnt signaling pathway Diagram ) inoh 56
TCF7L2 Canonical Wnt signaling pathway ( Canonical Wnt signaling pathway Diagram ) inoh 56
TCF7L2 Canonical Wnt signaling pathway ( Drosophila Wingless/Wnt signaling pathway Diagram ) inoh 56
TCF7L2 Canonical Wnt signaling pathway ( Mammalian Wnt signaling pathway Diagram ) inoh 56
TCF7L2 Canonical Wnt signaling pathway ( Xenopus axis formation Wnt signaling pathway Diagram ) inoh 56
TCF7L2 Deactivation of the beta-catenin transactivating complex reactome 42
TCF7L2 Formation of the beta-catenin:TCF transactivating complex reactome 88
TCF7L2 ID netpath 38
TCF7L2 Mammalian Wnt signaling pathway ( Mammalian Wnt signaling pathway Diagram ) inoh 49
TCF7L2 Regulation of nuclear beta catenin signaling and target gene transcription pid 80
TCF7L2 Repression of WNT target genes reactome 14
TCF7L2 Signaling with Wnt (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram ) inoh 47
TCF7L2 Signaling with Wnt (Canonical) ( Canonical Wnt signaling pathway Diagram ) inoh 47
TCF7L2 Signaling with Wnt (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram ) inoh 47
TCF7L2 Signaling with Wnt (Canonical) ( Mammalian Wnt signaling pathway Diagram ) inoh 47
TCF7L2 Signaling with Wnt (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram ) inoh 47
TCF7L2 Signaling with Wnt (Mammal) ( Mammalian Wnt signaling pathway Diagram ) inoh 47
TCF7L2 Signaling with Wnt (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram ) inoh 19
TCF7L2 Signaling without Wnt (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram ) inoh 8
TCF7L2 Signaling without Wnt (Canonical) ( Canonical Wnt signaling pathway Diagram ) inoh 8
TCF7L2 Signaling without Wnt (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram ) inoh 8
TCF7L2 Signaling without Wnt (Canonical) ( Mammalian Wnt signaling pathway Diagram ) inoh 8
TCF7L2 Signaling without Wnt (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram ) inoh 8
TCF7L2 Signaling without Wnt (Mammal) ( Mammalian Wnt signaling pathway Diagram ) inoh 8
TCF7L2 Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) reactome 20
TCF7L2 Wnt netpath 118
TCF7L2 Wnt signaling pathway panther 250
TCF7L2 Wnt signaling pathway kegg 135
TCF7L2 Adherens junction kegg 70
TCF7L2 Melanogenesis kegg 100
TCF7L2 Pathways in cancer kegg 321
TCF7L2 Colorectal cancer kegg 63
TCF7L2 Endometrial cancer kegg 52
TCF7L2 Prostate cancer kegg 85
TCF7L2 Acute myeloid leukemia kegg 53
TCF7L2 Arrhythmogenic right ventricular cardiomyopathy (ARVC) kegg 71
Enhancer Associated Network
Overlapping Enhancers (hg19) 11 found
Enhancer ID Position Tissue Cell Disease
E_04111 chr8:128412386-128415392 prostate gland malignant cell prostate cancer
E_04112 chr8:128412386-128415392 prostate gland malignant cell prostate cancer
E_04113 chr8:128412386-128415392 prostate gland malignant cell prostate cancer
E_03718 chr8:128412536-128414073 colon malignant cell colorectal carcinoma
E_03347 chr8:128413174-128414429 colon epithelial cell colorectal cancer
E_05003 chr8:128413174-128414429 colon malignant cell colorectal carcinoma
E_05004 chr8:128413174-128414429 colon malignant cell colorectal carcinoma
E_05005 chr8:128413174-128414429 colon malignant cell colorectal carcinoma
E_05006 chr8:128413174-128414429 colon malignant cell colorectal carcinoma
E_05007 chr8:128413174-128414429 colon malignant cell colorectal carcinoma
E_05008 chr8:128413174-128414429 colon malignant cell colorectal carcinoma
Expression of Target Genes for the Enhancer